Skip to content
This publication highlights the activities of the Alzheimer's Australia National Aboriginal and Torres Strait Islander Dementia Advisory Group (NATSIDAG) including information on dementia, resource development and service delivery for Aboriginal and Torres Strait Islander communities. The newsletter is produced with support provided by the Australian Government Department of Health and Ageing under the National Dementia Support Program.
This journal publishes new findings and new approaches to diagnosis and treatments to advance understandings of Alzheimer's disease and related disorders. The journal's primary target audience includes physicians and contributions fall within the following scientific fields and clinical specialities: neurobiology; neurochemistry; neuropsychology; psychiatry; gerontology; and geriatrics. The journal is published quarterly by Lippincott Williams & Wilkins.
This publication seeks to provide a forum whereby new findings or perspectives on Alzheimer's and dementia can be readily disseminated across disciplines to encourage the translation of research findings into practice. The journal publishes manuscripts from a range of disciplines (e.g., biochemistry, genetics, neurology, and sociology) and is interested in content that focus on: aetiology; risk factors; early detection; disease modifying interventions; prevention of dementia; and applications of new technologies in health services. The journal is published by Elsevier and six issues are produced each year.
This annual brings together basic sciences and clinical practice to inform interested persons of the latest developments in the field of dementia. Each annual includes a list of contemporary topics which endeavour to stimulate discussion on current and future treatment practices and approaches. The annual will be of particular interest to neurologists, psychiatrists, and geriatricians, and includes contributions from people who are internationally renowned experts in their respective fields.
This international, peer-reviewed journal is regarded as the major forum for translational research into Alzheimer's disease. It publishes basic research, clinical trials, research into drug discovery and development, and epidemiologic studies that focus primarily on Alzheimer's disease with scope extended to include other neurodegenerative diseases. The type of articles published by the journal include: research; commentary; editorial; letter; meeting report; review; and viewpoints. The journal makes research articles freely accessible online without subscription charges while other article types, such as reviews and commentaries, are only available by subscription.
Formerly known as Dementia, this journal is concerned with the study of cognitive dysfunction and publishes research on Alzheimer's and Parkinson's disease, Huntington's chorea, and other neurodegenerative diseases. The journal content is provided by a range of related disciplines including: psychogeriatrics; neuropsychology; clinical neurology; morphology; physiology; genetic molecular biology; pathology; biochemistry; immunology; pharmacology; and pharmaceutics. The journal publishes two volumes per year, with each volume containing six issues.
This journal seeks to improve the quality of life and quality of care of people with dementia through social research. The journal is directed at academics and practitioners from multiple clinical disciplines and is unique in that it is the first international research journal that focuses primarily on the lived experience of dementia. The journal accepts original research and original contributions to the field of social research and dementia, and is distributed quarterly in February, May, August, and November.
The International Journal of Alzheimer's Disease is a peer-reviewed journal that publishes original articles, review articles, case reports, and clinical studies pertaining to Alzheimer's disease. It is an open access journal meaning readers do not need to subscribe to view or download articles.
The Journal of Alzheimer's Disease is an international, multidisciplinary journal that aims to further understandings of Alzheimer's disease through publishing original research in the area. The journal publishes research reports, reviews, short communications, hypotheses, book reviews, and letters-to-the-editor that focus on the aetiology, pathogenesis, epidemiology, genetics, behaviour, treatment, and psychology of Alzheimer's disease. The journal is directed to an audience of science researchers and clinicians in the areas of Alzheimer's disease and related disorders, and is published in five volumes (each comprised of four issues) annually.